Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) had Free Cash Flow of $-5.27M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$0.17M |
|
$10.46M |
|
$0.42M |
|
$-0.25M |
|
$2.59M |
|
$-2.42M |
|
$12.88M |
|
$10.46M |
|
$10.46M |
|
$10.46M |
|
$10.46M |
|
$10.46M |
|
$10.46M |
|
$-2.42M |
|
$-2.42M |
|
0.84M |
|
0.84M |
|
$8.40 |
|
$8.40 |
|
| Balance Sheet Financials | |
$1.62M |
|
$9.69M |
|
$10.64M |
|
$12.26M |
|
$1.39M |
|
$0.28M |
|
$0.87M |
|
$2.26M |
|
$4.38M |
|
$10.00M |
|
$10.00M |
|
0.85M |
|
| Cash Flow Statement Financials | |
$-5.26M |
|
$-0.01M |
|
$1.44M |
|
$5.01M |
|
$1.17M |
|
$-3.84M |
|
$0.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.16 |
|
-- |
|
-- |
|
0.03 |
|
0.03 |
|
-148.21% |
|
-1440.48% |
|
-1440.48% |
|
-- |
|
6223.21% |
|
6223.21% |
|
|
Free Cash Flow |
$-5.27M |
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.38 |
|
240.00 |
|
238.92% |
|
104.52% |
|
85.27% |
|
101.67% |
|
$11.73 |
|
$-6.25 |
|
$-6.23 |
|